16
Natco Pharma Limited Regd. Off. : 'NATCO HOUSE', Road No. 2, Banjara Hills, Hyderabad - 500034. Telangana, INDIA. Tel : +91 40 23547532, Fax: +91 40 23548243 CIN: L24230TG1981PLC003201, www.natcophanna.co.in 24th June, 2019 Corporate Relationship Department M/ s. BSE ltd Manager - Listing M/ s. National Stock Exchange of India L td Exchange Plaza, Bandra - Kurla Complex Sandra (E) Mumbai -400 051 Dala l Street, Fort Mumbai- 400 001 Scrip Code : 524816 Scrip Code: NATCOPHARM Dear Sir Sub.: Disclosure in terms of Regulation · 10 (5) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 ("Takeover Regulations") and other int imations 1. This is to inform you that Ms Venkata Sat ya Swati Kantamani (the "Acquirer"), a member of th e promoter and promoter group of NATCO Pha rma Limited (" NATCO" ), proposes to acqui re 1,27, 23,340 shares constituting of 7.00% of the equity share capital of NATCO, by way of a gift from her immediate re lative, Mr V C Nannapaneni, as part of family restruc tur ing. Please find enclosed the disclosure under Regulation 10(5) of tbe Takeove r Regulations in this regard. 2. Separately, we wish to inform you that as part of the same family restructuring, Mr. V C Nannnapaneni proposes to transfer shares, by way of a gift , of the following promoter companies: a. M/ s. Timecap Pharma Labs Ltd., a member of the promoter and promot er group of NATCO, w hich holds 9.44% of the equity share capital in NATCO to (i) Mr . Rajeev Nannapaneni (h is son and a member of the promoter and promoter group of NATCO) and (ii) Vistra ITCL India Lim ited, a trustee of VCN Family Trust (Yistra ITCL India Limited is recognised as a member of the promoter and promoter group of NATCO). After the proposed transfers, there will be no change in the promoter and pr omoter group holding of NATCO. b. M/s. NATSOFT Information Systems Pvt Ltd, a member of the pro moter and promoter group of NATCO, which holds 8.67 % in NATCO to (i) Mr. Rajeev Na nnapaneni {his son and a member of the promoter and promoter group of NATCO) and (ii) Vistra ITCL India Limited, a t rustee of VCN family Trust (Vistra ITq In dia Limited is recognised as a member of the promoter and promoter group of NATCO) . After the propos ed transfers, there wi ll be no cha nge in the promoter and promoter group holding of NATCO. Thanking you M Adinarayana Company Secretary & Vice President (Legal & Corp A

Natco Pharma Limited - NSE

  • Upload
    others

  • View
    12

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Natco Pharma Limited - NSE

Natco Pharma Limited Regd. Off. : 'NATCO HOUSE', Road No. 2, Banjara Hills, Hyderabad - 500034.

Telangana, INDIA. Tel : +91 40 23547532, Fax: +91 40 23548243 CIN: L24230TG1981PLC003201, www.natcophanna.co.in

24th June, 2019

Corporate Relationship Department M/ s. BSE ltd

Manager - Listing M/ s. National Stock Exchange of India Ltd Exchange Plaza, Bandra - Kurla Complex Sandra (E) Mumbai -400 051

Dala l Street, Fort Mumbai- 400 001

Scrip Code: 524816 Scrip Code: NATCOPHARM

Dear Sir

Sub.: Disclosure in terms of Regulation · 10 (5) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 ("Takeover Regulations")

and other intimations

1. This is to inform you that Ms Venkata Satya Swati Kantamani (the "Acquirer"), a member of the promoter and promoter group of NATCO Pharma Limited (" NATCO" ), proposes to acquire 1,27,23,340 shares constituting of 7.00% of the equity share capital of NATCO, by way of a gift from her immediate re lative, Mr V C Nannapaneni, as part of fami ly restructuring. Please find enclosed the disclosure under Regulation 10(5) of tbe Takeover Regulations in this regard.

2. Separately, we wish to inform you that as part of the same family restructuring, Mr. V C Nannnapaneni

proposes to transfer shares, by way of a gift, of the following promoter companies :

a. M/ s. Timecap Pharma Labs Ltd., a member of the promoter and promoter group of NATCO, w hich holds 9.44% of the equity share capita l in NATCO to (i) Mr. Rajeev Nannapaneni (his son and a member of the promoter and promoter group of NATCO) and (ii) Vistra ITCL India Limited, a trustee of VCN Family Trust (Yistra ITCL India Limited is recognised as a member of the promoter and promoter group of NATCO). After the proposed transfers, there will be no change in the promoter and promoter group holding of NATCO.

b. M/s. NATSOFT Information Systems Pvt Ltd, a member of the promoter and promoter group of NATCO, which holds 8.67 % in NATCO to (i) Mr. Rajeev Nannapaneni {his son and a member of the promoter and promoter group of NATCO) and (ii) Vistra ITCL India Limited, a t rustee of VCN family

Trust (Vistra ITq India Limited is recognised as a member of the promoter and promoter group of NATCO). After the proposed transfers, there will be no change in the promoter and promoter group hold ing of NATCO.

Thanking you

M Adinarayana Company Secretary & Vice President (Legal & Corp A

Page 2: Natco Pharma Limited - NSE

Disclosure under Regulation 10(5) - Intimation to Stock Exchanges in respect of acquisitions under Regulation

lO{l)(a) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

1 Name of the Target Company NATCO Pharma Limited

2 Name of the Acquirer(s) Ms Venkata Satya Swati Kantamanl ("Acquirer'' )

3 Whether the acquirer (s) is I are Yes,. the acquirer is a member of the promoter and promoter

promoters of the TC prior to the group of NATCO transaction. If no, nature of relationship or association with the TC or its promoters

4 Details of the proposed acquisition a Name of the person (s) from Mr V C Nannapaneni

whom shares are to be acquired b Proposed date of Acquisition On or after 29 June 2019

c Number of Shares to be acquired from each person mentioned in 4 1,27,23,340 shares constituting of 7 .00 % of the total share (a) above capital of NATCO

d Total shares to be acquired as% of share Capital of TC

e Price at which shares are There is no consideration involved as the proposed transfer proposed to be acquired of ~hares is by way of a Gift to the Acquirer from her

immediate relative {being father in law). f Rationale, if any, for the Gift to immediate relatives. Mr V C Nannapaneni (transferor)

proposed transfers is the father-in-law of the Acquirer.

5 Relevant sub- clause of regulation Regulation lO(l)(a) of t he SEBI SAST Regulations. lO(l)(a) under which the acquirer is exempted from making open offer

6 If, frequently traded, volume weighted The shares of TC are frequent ly traded in National Stock average market price·for a period of Exchange. The volume weighted average market price for a 60 trading days preceding the date of period of 60 trading days preceding the date of issuance of issuance of this notice as traded on this notice is Rs.539.64 the stock exchange where the maximum volume of trading in the share of the TC are recorded during such period.

7 If in-frequently traded, the price as Not.Applicable determined in terms of clause( of sub-regulation (2) of regulation 8.

8 Declaration by the acquirer, that the Not Applicable acquisition price would not be higher by more t hen 25% of the price computed in point 6 or point 7 as applicable.

9 i Declaration by the acquirer, that The Acquirer confirms that the transferor and the transferees the transferor and transferee have complied (during 3 years prior to the date of proposed have complied (during 3 years acquisition)/ will comply with the applicable disclosure prior to the date of proposed requirements in Chapter V of the Takeover Regulations, 2011 acquisition) I will comply with (corresponding provisions of the repealed Takeover applicable disclosure requirement Regulations 1997).

Page 3: Natco Pharma Limited - NSE

!

ii The aforesaid disclosures made Copies of the disclosures made during the previous 3 years during previous 3 years prior to prior to the date of proposed acquisition enclosed as the date of proposed acquisition Annexure to be furnished

10 Declaration by the acquirer that all the All the conditions specified under Regulation (10(1)(a) of conditions specified under regulation the SEBI SAST Regulations with respect to exemptions has 10 (1) (a) with respect to exemptions been duly complied with has been duly complied with

11 Before the proposed After the proposed transaction transaction

Shareholding details No of % w.r.t No of % w.r.t total shares I total shares I shares capital of

Voting shares Voting TC Rights capital of Rights

TC a Acquirer(s) PACs I

( other than sellers) (*) 5,37,70,375 29.582 6,64,93,715 36.582

Please refer to the Schedule for the shareholding of the acquirer and PACs B Seller (s)

- V C Nannapaneni 3,53,11,270 19.427 2,25,87,930 12.427

Note:

• (*) Shareholding of each entity may be shown separately and then collectively in a group.

• The above disclosure shall be signed by the acquirer mentioning date & place. In case, there is more than one acquirer, the report shall be signed either by all the persons or by a person duly authorized to do so on behalf of all the acquirers.

Venkata Satya Swathi Kantamani

Place: Hyderabad

Date : 24/06/2019

Page 4: Natco Pharma Limited - NSE

SHAREHOLDING OF THE ACQUIRER AND PACs (EXCLUDING THE SELLERS)

Before the proposed After the proposed transaction transaction

NAME OF ACQUIRER AND PACs No of %To No of %To

Shares Total PC Shares Total PC

VENKATA SATYA SWATHI KANTAMANI 3260000 1.79 15983340 8.79

VENKAIAH CHOWDARY NANNAPANENI HUF 5440045 2.99 5440045 2.99 KANTAMANI RATNA KUMAR 100000 0.06 100000 0.06

DURGA DEVI NANNAPANENI 1128760 0.62 1128760 0.62 RAJEEV NANNAPANENI 1099800 0.61 1099800 0.61 RAMAKRISHNA RAO NANNAPANENI 746910 0.41 746910 0.41 NEELIMA SITA NANNAPANENI 182960 0.10 182960 0.10

DEVENDRANTH ALAPATI 15000 0.01 15000 0.01 BAPANNA ALAPATI 18300 0.01 18300 0.01 BAPINEEDU TUMMALA 415 0.00 415 0.00

TUM MALA JANSI 77100 0.04 77100 0.04

T ANANDA BABU 473205 0.26 473205 0.26 VIDYADHARI TUM MALA 442200 0.24 442200 0.24 T ANILA 629920 0.35 629920 0.35 NATSOFT INFORMATION SYSTEMS PVT LTD 15767500 8.67 15767500 8.67

TIME CAP PHARMA LABS LIMITED 17157220 9.44 17157220 9.44 NATCO AQUA LIMITED 16000 0.01 16000 0.01 NDL INFRATECH PRIVATE LIM ITED 93750 0.05 93750 0.05 Vistra ITCL India Limited 4082750 2.25 4082750 2.25 Vistra ITCL (India) Limited 600000 0.33 600000 0.33

DURGADEVI NANNAPANENI 2410340 1.33 2410340 1.33

RAJEEV N 28200 0.02 28200 0.02

Total 53770375 29.58 66493715 36.58

Page 5: Natco Pharma Limited - NSE

1st April, 2017 Corporate Relationship Department The Manager – Listing M/s. BSE Ltd M/s. National Stock Exchange of India Ltd Dalal Street, Fort “Exchange Plaza”, Bandra – Kurla Complex Mumbai 400 001 Bandra (E) Mumbai 400 051 Scrip Code: 524816 Scrip Code: NATCOPHARM Dear Sir

Sub:- Disclosures under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares and

Takeovers) Regulations, 2011 Please find enclosed herewith the Disclosures received from Sri V C Nannapaneni , under regulation (s) 30(1) & 30(2) of SEBI (substantial Acquisition of Shares and Takeovers) Regulations, 2011 as on 31st March, 2017. Thanking you Yours faithfully For NATCO Pharma Limited

M Adinarayana Company Secretary & Vice President (Legal & Corp Affairs)

Page 6: Natco Pharma Limited - NSE

Format for Disclosures under Regulation 30{1} & 30(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

1. Name of the Target Company (TC) NATCO Pharma Limited 2. Name (s) of the Stock Exchange(s) where the National Stock Exchange & BSE Ltd

shares of the TC are listed 3. Particulars of the Shareholder

a. Name of person whose total holding (including that in the form of shares, warrants, convertible securities and any other instrument that would entitle the holder to receive shares in the target company) is more that 25% of the shares or Voting rights of the TC

OR V C NANNAPANENI on behalf of himself, as a b. Name(s) of Promoter(s), member of the Promoter and persons Acting in Concert (*) and promoter group and persons acting in concert promoter group (PAC) with him

4. Particulars of the holding of persons Number % w.r.t. total % w.r.t. total mentioned at (3) above share/vot ing diluted

capital share/voting whereve r capital of applicable the TC(*)

5. As on March 31, 2017, holding of a. Shares 89322320 51.24 51.24

b. voting Rights (other wise that by shares) - - -c. Warrants - - -d. Convertible Securities. - - -e. Any other instrument that would entitle the - -

holder to receive shares in the TC.

(* ) persons acting in concert and promoter group Details and their share holding is attached as Annexure

Place: Hyderabad Date : 11h April, 2017

Sign ure of Auth ed Signatory: (V C Nannapaneni on behalf of himself, And Persons Acting in Concert)

Page 7: Natco Pharma Limited - NSE

Annexure

Details of shareholding of Promoters and Promoter Group persons along with Persons Acting in concert as on March 31, 2017

Name of the Promoter/ persons acting in concert persons

V C Nannapaneni (including HUF) Durga Devi Nannapaneni Rajeev Nannapaneni Neelima Sita Nannapaneni Venkata Satya Swath i Kantamani Time Cap Pharma Labs Ltd

Natsoft Information Systems Pvt Ltd Natco Aqua Limited

Ndl Infra Tech Pvt Ltd N Ramakrishna Rao T Ananda Babu T Vidyadhari T Jhansi T Anila llfs Trust Company Ltd Ale Neelima Nannapaneni Trust

llfs Trust Company Ltd Ale Durga Devi Nannapaneni Trust

Kantamani Ratna Kumar TBapineedu Devendrnath Alapati Bapanna Alapati

Total

Place: Hyderabad Date : 1'1 April, 2017

Number

40736815 3539100 1676175

182960 2860000

17157220 15767500

16000 93750

746410 473205 442200 247100 629920

4082750

600000

37500 415

15000 18300

89322320

% w.r.t. % w.r.t. total total diluted share/voting share/ voting capital capital of wherever the TC(*) applicable

23.37 23.37 2.03 2.03 0.96 0.96 0.10 0.10 1.64 1.64 9.84 9.84 9.05 9.05 0.01 0.01 0.05 0.05 0.43 0.43 0.27 0.27 0.25 0.25 0.14 0.14 0.36 0 .36

2.34 2.34

0.34 0.34

0.02 0.02 0.00 0.00 0.01 0.01 0.01 0.01

51.24 51.24

Sign ture of Authorized Signatory: {V C Nannapaneni on behalf of himself, And Persons Acting in Concert)

Page 8: Natco Pharma Limited - NSE

Name(s) of the person and Persons Acting in Concert (PAC) with the person

V C Nannapaneni (including HUF) Durga Devi Nannapaneni Rajeev Nannapaneni

Neelima Sita Nannapaneni

Venkata Satya Swathi Kantamani

Time Cap Pharma Labs Ltd Natsoft Information Systems Pvt Ltd

Natco Aqua Limited Ndl Infra Tech Pvt Ltd N Ramakrishna Rao T Ananda Babu T Vidyadhari

T Jhansi

T Anila llfs Trust Company Ltd Ne Neelima Nannapaneni Trust l lfs Trust Company Ltd Ne Durga Devi Nannapaneni Trust Kantamani Ratna Kumar TBapineedu Devendrnath Alapati

Bapanna Alapati

Place: Hyderabad Date: 01/04/2017

'

Whether the person belongs PAN of the person and to Promoter/ Promoter group PA Cs

Promoter AABHN7619B Promoter ABEPN6213F Promoter ABIPN9746K

Promoter ABIPN9748H Promoter Group AQCPK7971Q

Promoter Group AAACT8345C

Promoter Group AAACN8056E

Promoter Group AABCN2627E

Promoter Group AABCN6521D Promoter Group ABIPN9747J Promoter Group AEWPT8476R Promoter Group AFBPT7439J

Promoter Group ADWPT8310M

Promoter Group AFGPT6537A

Promoter AABTN7202Q

Promoter AACTD1349R

Promoter Group AAXPK9896R

Promoter Group ACIPT7817Q

Promoter Group ABQPA4117P

Promoter Group ABQPA4118C

Page 9: Natco Pharma Limited - NSE

April 6, 2018

Corporate Relationsh ip Department M/s. SSE Ltd Da lal Street, Fort Mumbai 400 001

Scrip Code: 524816

Dear Sir

N atco Pharma Limited Regd. Off. : 'NATCO HOUSE', Road No. 2, Banjara Hills, Hyderabad - 500034.

Telangana, INDIA. Tel : +91 40 23547532, Fax : +91 40 23548243 CIN: L24230TG1981PLC003201, www.natcopharma.co.in

The Manager - listing M/s. National Stock Exchange of India Ltd "Exchange Plaza", Sandra - Kurla Complex Sandra (E) Mumbai 400 051

Scrip Code: NATCOPHARM

Sub:- Disclosures under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

Please find enclosed herewith the Disclosures received from Sri V C Nannapaneni, under regulation (s) 30(1) & 30(2) of SEBI (substantial Acquisition of Shares and Takeovers) Regulations, 2011 as on 3l51

March, 2018.

Thanking you

Yours faithfully For NATCO Pharma limited

~~ M Adinarayana

Company Secretary & Vice President (Legal & Corp Affairs)

Page 10: Natco Pharma Limited - NSE

Format for Disclosures under Regulation 30(1) & 30(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

l. Name of the Target Company (TC) NATCO Pharma Limited 2. Name (s) of the Stock Exchange(s) where the National Stock Exchange & BSE Ltd

shares of the TC are listed 3. Particula rs of the Shareholder

a. Name of person whose total holding (including that in the form of shares, warrants, convertible securities and any other instrument that would entitle the holder to rece ive shares in the target company) is more that 25% of the shares or Voting rights of the TC

OR V C NANNAPANENI on behalf of himself, as a b. Name(s) of Promoter(s), member of the Promoter and persons Acting in Concert (*) and promoter group and persons acting in concert promoter group (PAC) with him

4. Particulars of the holding of persons Number % w.r.t . total % w.r.t. total mentioned at (3) above share/voting diluted

capital share/voting wherever capital of applicable the TC(*)

5. As on March 31, 2017, holding of a. Shares 89251845 48.38 48.38 b. voting Rights (other wise that by shares) - - -c. Warrants - - -d. Convertible Securities. - - -e. Any other instrument that would entitle the - -

holder to receive shares in the TC.

(*) persons acting in concert and promoter group Details and their share holding is attached as Annexure

Place: Hyderabad Date : April 6, 2018

- c=:S'\ ™»UC) ~ Signature of Authorized Signatory: (V C Nannapaneni on behalf of himself, And Persons Acting in Concert)

Page 11: Natco Pharma Limited - NSE

Annexure

Details of shareholding of Promoters and Promoter Group persons along with Persons Acting in concert as on March 31, 2018

Name of the Promoter I persons acting in concert persons

V C Nannapaneni (including HUF) Durga Devi Nannapaneni Rajeev Nannapaneni Neelima Sita Nannapaneni Venkata Satya Swathi Kantamani Time Cap Pharma Labs Ltd Natsoft Information Systems Pvt Ltd Natco Aqua Limited Ndl Infra Tech Pvt Ltd N Ramakrishna Rao

T Ananda Babu T Vidyadhari T Jhansi T Anila

Vistra ITCL India Limited Ale Neelima Nannapaneni Trust

llfs Trust Company Ltd Ale Durga Devi Nannapaneni Trust

Kantamani Ratna Kumar TBapineedu Devendrnath Alapati Bapanna Alapati

Place: Hyderabad Date : April 6, 2018

Number

40751315 3539100 1128000

182960 3260000

17157220 15767500

16000 93750

747110 473205 442200 247100 629920

4082750

600000

100000 415

15000 18300

% w.r.t. % w.r.t . total total diluted share/voting share/voting capital capital of wherever the TC(*) applicable

22.09 22.09 1.92 1.92 0.61 0.61 0.10 0 .10 1.77 1.77 9.30 22.09 8.55 8.55 0.01 0.01 0.05 0.05 0.40 0.40 0.26 0.26 0.24 0.24 0.13 0.13 0.34 0.34 2.21 2.21

0.33 0.33

0.05 0.05 0.00 0.00 0.01 0.01 0.01 0.01

Signature of Authorized Signatory: (V C Nannapaneni on behalf of himself, And Persons Acting in Concert)

Page 12: Natco Pharma Limited - NSE

-

Name(s) of the person and Persons Acting in Concert (PAC) with the person

V C Nannapaneni (including HUF)

Durga Devi Nannapaneni Rajeev Nannapaneni

Neelima Sita Nannapaneni Venkata Satya Swathi Kantamani

Time Cap Pharma Labs Ltd Natsoft Information Systems Pvt Ltd Natco Aqua Limited

Ndl Infra Tech Pvt Ltd

N Ramakrishna Rao T Ananda Babu T Vidyadhari T Jhansi

T Anila

Vistra ITCL India Limited AJc Neelima Nannaoaneni Trust llfs Trust Company Ltd AJc Durqa Devi Nannaoaneni Trust Kantamani Ratna Kumar TBapineedu Devendrnath Alapati

Bapanna Alapati

~!!!,~ ' S;;ture of the Authorised Signatory

Place: Hyderabad Date: April 6, 2018

Whether the person belongs PAN of the person and to Promoter/ Promoter group PACs

Promoter AABHN7619B & ABEPN6301L

Promoter ABEPN6213F

Promoter ABIPN9746K

Promoter ABIPN9748H Promoter Group AQCPK7971Q Promoter Group AAACT8345C Promoter Group AAACN8056E Promoter Group AABCN2627E Promoter Group AABCN6521D Promoter Group ABIPN9747J

Promoter Group AEWPT8476R Promoter Group AFBPT7439J

Promoter Group ADWPT8310M

Promoter Group AFGPT6537A

Promoter AABTN7202Q

Promoter AACTD1349R

Promoter Group AAXPK9896R

Promoter Group ACIPT7817Q

Promoter Group ABQPA4117P

Promoter Group ABQPA4118C

Page 13: Natco Pharma Limited - NSE

April 4, 2019

Corporate Relationship Department M/s. BSE Ltd Dalal Street, Fort Mumbai 400 001

Scrip Code: 524816

Dear Sir

N atco Pharma Limited Regd. Off. : 'NATCO HOUSE', Road No. 2, Banjara Hills, Hyderabad - 500034.

Telangana , INDIA. Tel : +91 40 23547532, Fax : +91 40 23548243 CTN: L24230TG1981PLC003201, www.natcopharma.co.in

The Manager - Listing M/s. National Stock Exchange of India Ltd "Exchange Plaza", Bandra - Kurla Complex Bandra (E) Mumbai 400 051

Scrip Code: NATCOPHARM

Sub:- Disclosures under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

Please find enclosed herewith the Disclosures received from Sri V C Nannapaneni , under regulation (s) 30(1) & 30(2) of SEBI (substantial Acquisition of Shares and Takeovers) Regulations, 2011 as on 3pt March, 2019.

Thanking you

Yours faithfully For NATCO Pharma Limited

('--v~k ~~~ .. c,,1

M Adinarayana Company Secretary & Vice President (Legal & Corp Affairs)

Page 14: Natco Pharma Limited - NSE

Format for Disclosures under Regulation 30(1) & 30(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

1. Name of t he Target Company (TC) NATCO Pharma Limited 2. Name (s) of the Stock Exchange(s) where the National Stock Exchange & BSE Ltd

shares of the TC are listed 3. Particulars of the Shareholder

a. Name of person whose total holding (including that in the form of shares, warrants, convertible securities and any other instrument that wou ld entit le the holder to receive shares in the target company) is more that 25% of the shares or Voting rights of the TC

OR V C NANNAPANENI on behalf of himself, as a b. Name(s) of Promoter(s), member of the Promoter and persons Acting in Concert (*) and promoter group and persons acting in concert promoter group (PAC) with him

4. Particulars of the holding of persons Number % w.r.t. total % w.r.t. total mentioned at (3) above share/voting diluted

capital share/voting wherever capital of applicable the TC(*)

5. As on March 31, 20!9, holding of a. Shares 89081845 49.71 49.71

b. voting Rights (other wise that by shares) - - -c. Warrants - - -d. Convertible Securities. - -e. Any other instrument that would entitle the -

holder to receive shares in the TC.

(*) persons acting in concert and promoter group Details and their share holding is attached as Annexure

Place: Hyderabad Date : April 4, 2019

Page 15: Natco Pharma Limited - NSE

Annexure

Details of shareholding of Promoters and Promoter Group persons along with Persons Acting in concert as on March 31, 2019

Name of the Promoter I persons acting in concert persons

V C Nannapaneni

V C Nannapaneni HUF Durga Devi Nannapaneni Rajeev Nannapaneni

Neelima Sita Nannapaneni

Venkata Satya Swathi Kantamani Time Cap Pharma Labs Ltd

Natsoft Information Systems Pvt Ltd Natco Aqua Limited

Ndl Infra Tech Pvt Ltd N Ramakrishna Rao

T Ananda Babu T Vidyadhari T Jhansi

T Anila

Vistra ITCL India Limited Ale Neelima Nannapaneni Trust

VISTRA ITCL (INDIA} LIMITED A/ c Durga Devi Nannapaneni Trust

Kantamani Ratna Kumar

TBapineedu Devendrnath Alapati Bapanna Alapati

Place: Hyderabad Date : April 4, 2019

Number

35311270 5440045 3539100 1128000

182960 3260000

17157220 15767500

16000 93750

747110 473205 442200

77100 629920

4082750

600000

100000 415

15000 18300

% w.r.t. % w.r.t . total total diluted share/voting share/voting capital capital of wherever the TC(*) aoolicable

19.31 19.31 2.97 2.97 1.94 1.94 0.62 0.62 0.10 0.10 1.78 1.78 9.38 9.38 8.62 8.62 0.01 0.01 0.05 0.05 0.41 0 .41 0.26 0 .26 0.24 0.24 0.04 0 .04 0.34 0.34 2.23 2.23

0.33 0.33

0.05 0.05 0.00 0.00 0.01 0.01 0.01 0.01

Signature of Aut orized Signatory: (V C Nannapaneni on behalf of himself, And Persons Acting in Concert)

Page 16: Natco Pharma Limited - NSE

Name(s) of the person and Persons Acting in Concert (PAC) with the person V C Nannapaneni V C Nannapaneni HUF

Durga Devi Nannapaneni Rajeev Nannapaneni Neelima Sita Nannapaneni

Venkata Satya Swathi Kantamani

Time Cap Pharma Labs Ltd Natsoft Information Systems Pvt Ltd

Natco Aqua Limited Ndl Infra Tech Pvt Ltd N Ramakrishna Rao T Ananda Babu T Vidyadhari

T Jhansi

T Anila

Vistra ITCL India limited Ale Neelima Nannapaneni Trust llfs Trust Company Ltd Ale Duraa Devi Nannaoaneni Trust Kantamani Ratna Kumar TBapineedu Devendrnath Alapati Bapanna Alapati

Signature of the Authorised Signatory

Place: Hyderabad Date: April 4, 2019

Whether the person belongs PAN of the person and

to Promoter/ Promoter group PACs

Promoter ABEPN6301L

Promoter AABHN7619B

Promoter ABEPN6213F Promoter ABIPN9746K Promoter ABIPN9748H

Promoter Group AQCPK7971Q

Promoter Group AAACT8345C Promoter Group AAACN8056E

Promoter Group AABCN2627E Promoter Group AABCN6521D

Promoter Group ABIPN9747J Promoter Group AEWPT8476R Promoter Group AFBPT7439J

Promoter Group ADWPT8310M

Promoter Group AFGPT6537A

Promoter AABTN7202Q

Promoter AACTD1349R

Promoter Group AAXPK9896R Promoter Group ACIPT7817Q Promoter Group ABQPA4117P

Promoter Group ABQPA4118C